Have a personal or library account? Click to login
Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in metastatic castration-resistant prostate cancer patients candidates to 223RaCl treatment Cover

Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in metastatic castration-resistant prostate cancer patients candidates to 223RaCl treatment

Radiology and Oncology
Volume 54 (2020): Issue 1 (March 2020)
By: Viviana Frantellizzi,  Arianna Pani,  Maria Dea Ippoliti,  Alessio Farcomeni,  Irvin Aloise,  Mirco Colosi,  Claudia Polito,  Roberto Pani and  Giuseppe De Vincentis  
Open Access
|Dec 2019
DOI: https://doi.org/10.2478/raon-2019-0058 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 40 - 47
Submitted on: Jun 18, 2019
|
Accepted on: Oct 22, 2019
|
Published on: Dec 19, 2019
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
DASciS software,
radium223 dichloride,
bone scan index,
bone disease,
overall survival,
mCRPC
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2019 Viviana Frantellizzi, Arianna Pani, Maria Dea Ippoliti, Alessio Farcomeni, Irvin Aloise, Mirco Colosi, Claudia Polito, Roberto Pani, Giuseppe De Vincentis, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 54 (2020): Issue 1 (March 2020)Next article